Rare diseases
Investigational molecules
Locations
Back to Czechia743 clinical trials in Brno, Czechia across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Orforglipron for stress urinary incontinence in women with obesity or overweight
CzechiaStudy of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity
CzechiaA Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
CzechiaPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
CzechiaPhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
CzechiaEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
CzechiaA Randomized Trial of lu af28996 dh1 to Reduce Motor Fluctuations in Adults with Parkinson’s Disease
CzechiaPhase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
CzechiaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
CzechiaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
CzechiaLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for leukemia, prostate cancer, and gastric cancer.
Studies evaluating novel therapeutic combinations and targeted treatments for various cancer types.
Research focused on treating inflammatory disorders and autoimmune conditions, with particular emphasis on innovative therapies.
Evaluating new biological treatments and their long-term effectiveness in managing chronic conditions.
Studies addressing respiratory diseases and heart conditions, focusing on prevention and treatment strategies.
Testing innovative approaches to improve patient outcomes in respiratory and cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
